On the prevention of kidney uptake of radiolabeled DARPins
Abstract Background Designed ankyrin repeat proteins (DARPins) are small engineered scaffold proteins (14–18 kDa) that demonstrated promising tumor-targeting properties in preclinical studies. However, high renal accumulation of activity for DARPins labeled with residualizing labels is a limitation...
Main Authors: | Mohamed Altai, Javad Garousi, Sara S. Rinne, Alexey Schulga, Sergey Deyev, Anzhelika Vorobyeva |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-02-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13550-020-0599-1 |
Similar Items
-
Influence of Several Compounds and Drugs on the Renal Uptake of Radiolabeled Affibody Molecules
by: Javad Garousi, et al.
Published: (2020-06-01) -
Investigation of a Pharmacological Approach for Reduction of Renal Uptake of Radiolabeled ADAPT Scaffold Protein
by: Anzhelika Vorobyeva, et al.
Published: (2020-09-01) -
Indirect Radioiodination of DARPin G3 Using N-succinimidyl-<i>Para</i>-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging
by: Anzhelika Vorobyeva, et al.
Published: (2019-06-01) -
Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1
by: Sergey M. Deyev, et al.
Published: (2021-07-01) -
Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1
by: Anzhelika Vorobyeva, et al.
Published: (2020-05-01)